Resources by Therapeutic Area
Quanterix Extends Oncology Footprint with Accelerated Launch of Next Gen SP-X™ Platform and CorPlex™ Validated 10-Plex
Following successful beta program, the Simoa SP-X next generation benchtop and CorPlex are launching ahead of schedule to further revolutionize cancer research, immunotherapy monitoring, and drug development
The Quanterix SP-X Imaging and Analysis System is the first complete benchtop system offering true multiplex detection capabilities at both acute and baseline levels.
Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX(R) and Quanterix SiMoA methodologies
Poorbaugh J, Samanta T, Bright SW, Sissons SE, Chang CY, Oberoi P, MacDonald AJ, Martin AP, Cox KL and Benschop RJ. J Immunol Methods. 2018 DOI: https://doi.org/10.1016/j.jim.2018.12.005 Abstract
Fadlallah J, Sterlin D, Fieschi C, Parizot C, Dorgham K, El Kafsi H, Autaa G, Ghillani-Dalbin P, Juste C, Lepage P, Malphettes M, Galicier L, Boutboul D, Clement K, Andre S, Marquet F, Tresallet C, Mathian A, Miyara M, Oksenhendler E, Amoura Z, Yssel H, Larsen M and Gorochov G.
Measuring total IFNα at fg/mL concentrations in human blood using ultra-sensitive digital immunoassays
EBF 2018, Barcelona Spain Martha Miles, Milena Milutinovic, Evan Ferrell, Jason Wickman, Lei Chang, Joe Johnson ABSTRACT: